EL PRIMER PASO DE LA PALEONTOLOGIA. UNA CONFIRMACION QUE ILEGA DESPUES DE 25 SIGLOS. = LE PREMIER PAS DE LA PALEONTOLOGIE. UNE CONFIRMATION ATTENDUE DEPUIS 25 SIECLESIMPERATORI L.1977; BOL. R. SOC. ESP. HIST. NAT., SECC. GEOL.; ESP.; DA. 1977; VOL. 75; NO 1-4; PP. 77-83; 5 ILL.Article

DOCUMENTOS PARA EL ESTUDIO DEL CUATERNARIO ALICANTINO.IMPERATORI L.1966; ESTUD. GEOL.; ESP; 1966(12), VOL. 22, P. 229 A 233Miscellaneous

Dons d'organes et transplantation: qu'en pensent les soignants ? : Soins intensifs = What do hospital staff think of organ donation and transplantation ?IMPERATORI, L; GACHET, C; ECKERT, P et al.Médecine et hygiène. 2001, Vol 59, Num 2372, pp 2463-2467, issn 0025-6749, 4 p.Article

3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agentsIMPERATORI, L; DAMIA, G; TAVERNA, P et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 3, pp 533-537, issn 0143-3334Article

Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833GONZALEZ, O; COLOMBO, T; DE FUSCO, M et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 4, pp 335-340, issn 0344-5704Article

In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatinBELVEDERE, G; IMPERATORI, L; DAMIA, G et al.European journal of cancer (1990). 1996, Vol 32, Num 11, pp 2011-2018, issn 0959-8049Article

Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trialMATTIOLI, R; LIPPE, P; LAICI, G et al.Anticancer research. 2004, Vol 24, Num 5B, pp 3257-3261, issn 0250-7005, 5 p.Article